Cancer Research

LIVE September 22nd, 2021 at 2:30 PM ET
Scientists will discuss how they identify and design new cell-based anticancer treatments and how they balance the need for potency with the specter of side effects.

Scientists found evidence of telomeres in the 1930s, but did not identify them until the 1970s. Since then, researchers’ understanding of telomeres and their role in DNA repair, aging, and disease has expanded exponentially.

New directions for cell therapy extend beyond T cells and cancer treatment.

Researchers use machine learning to identify generic drugs that are promising candidates for affordable and accessible cancer treatments.

Christine Brown develops CAR T cell therapies that may one day provide a long-sought-after cure for malignant brain cancers.

New technology turns red blood cells into artificial antigen-presenting cells. These cells activate T cells to attack HPV-driven cancers.

Scientists discovered a long sought-after inhibitor for the DNA repair polymerase, Polθ, which may be key to treating drug-resistant BRCA1 and BRCA2-mutant cancers.

Classical model systems such as cell culture and mice are key to understanding cancer. But what can we learn by examining how cancer works in other models? Animals like naked mole rats and Tasmanian devils offer a new perspective on how cancer works and how we can treat it.

A new molecule in Phase 1 clinical trials kills leukemia cells by blocking their ability to repair DNA.

Epidemiologists may have found the perfect method to delineate if long-term use of antihypertensive medications increases cancer risk.